Polat Irmak, Ince Guliyev Ezgi, Elmas Sibel, Karakaş Sufiya, Aydemir Ömer, Üçok Alp
Department of Psychiatry, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Department of Psychiatry, Erenkoy Training and Research Hospital for Mental and Neurological Diseases, University of Health Sciences, Istanbul, Turkey.
Int J Psychiatry Clin Pract. 2022 Sep;26(3):221-227. doi: 10.1080/13651501.2022.2082985. Epub 2022 Jun 14.
The Self-Evaluation of Negative Symptoms Scale (SNS) is a self-report scale that evaluates a patient's subjective experience on all five domains of the negative symptoms. This study aimed to present the adaptation and validation study of the Turkish version of SNS(SNS-TR).
Seventy-five patients and 50 controls were recruited for this study. After the approval of the translation, participants were asked to fill out SNS-TR by themselves. They were interviewed with the Brief Negative Symptoms Scale (BNSS), Positive and Negative Syndrome Scale (PANSS), and Calgary Depression Scale for Schizophrenia (CDSS).
SNS-TR showed good internal consistency in the reliability analysis with Cronbach's alpha= 0.873. Subscale-total score correlation coefficients were significant ( < 0.01). In the validity analyses, the total and subscale scores of SNS-TR showed positive correlations with the total and subscales of BNSS, with only one exception of BNSS lack of distress subscales. The total score of SNS-TR demonstrated a significant correlation with PANSS-total, PANSS-negative subscale, PANSS-general subscale, and CDSS scores. Confirmatory factor analysis showed acceptable values for the five-factor structure, similar to the original version.
To conclude, our study indicates that SNS-TR is an easily applicable self-evaluation tool with good psychometric properties for assessing negative symptoms. KEY POINTSSNS is a novel and easily applicable self-report scale for examining negative symptoms in schizophrenia patients, allowing them to evaluate their subjective experience on all five domains of the negative symptoms.It shows good internal consistency (α= 0.873) which is similar to the original version (α = 0.867).Confirmatory factor analysis scores were found in acceptable ranges and SNS-TR confirm the five-factor structure.Using this scale in clinical practice would empower both the physician's examinations and patient participation through treatment and follow-up course.
阴性症状自评量表(SNS)是一种自评量表,用于评估患者在阴性症状所有五个维度上的主观体验。本研究旨在介绍SNS土耳其语版(SNS-TR)的改编与验证研究。
本研究招募了75名患者和50名对照。翻译获得批准后,要求参与者自行填写SNS-TR。对他们进行了简明阴性症状量表(BNSS)、阳性与阴性症状量表(PANSS)以及精神分裂症卡尔加里抑郁量表(CDSS)的访谈。
在可靠性分析中,SNS-TR显示出良好的内部一致性,克朗巴哈系数α=0.873。分量表总分相关系数显著(<0.01)。在效度分析中,SNS-TR的总分和分量表得分与BNSS的总分和分量表呈正相关,只有BNSS缺乏痛苦分量表这一例外。SNS-TR的总分与PANSS总分、PANSS阴性分量表、PANSS一般分量表和CDSS得分显著相关。验证性因素分析显示五因素结构的值可接受,与原始版本相似。
总之,我们的研究表明SNS-TR是一种易于应用的自评工具,具有良好的心理测量特性,可用于评估阴性症状。要点SNS是一种新颖且易于应用的自评量表,用于检查精神分裂症患者的阴性症状,使他们能够评估自己在阴性症状所有五个维度上的主观体验。它显示出良好的内部一致性(α=0.873),与原始版本相似(α=0.867)。验证性因素分析得分在可接受范围内,SNS-TR证实了五因素结构。在临床实践中使用该量表将通过治疗和随访过程增强医生的检查和患者的参与度。